Advertisement

Hidradenitis suppurativa: A review of post-operative outcomes

Published:August 19, 2020DOI:https://doi.org/10.1016/j.bjps.2020.08.026
      Hidradenitis suppurativa (HS) is a chronic, debilitating disease where even surgery, which is considered the ‘gold standard’ treatment, often has poor outcomes. With the current COVID-19 pandemic, the authors believe it important to make patients aware of the likely surgical outcomes of non-essential surgery. The authors’ aim is to present the complication rates, healing times and risk of recurrence of HS surgery from a London hospital in order to better consent HS patients accurately and offer some comparison with similar studies from other countries.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fertitta L.
        • Hotz C.
        • Wolkenstein P.
        • Meningaud J.P
        • Sawan D.
        • Hersant B.
        • Sbidian E.
        Efficacy and satisfaction of surgical treatment for hidradenitis suppurativa.
        J Eur Acad Dermatol Venereol. 2020; 34: 839-845
        • Ovadja Z.
        • Bartelink S.
        • van de Kar A.
        • van der Horst C.
        • Lapid O
        A multicenter comparison of reconstruction strategies after wide excision for severe axillary hidradenitis suppurativa.
        Plas Reconstr Surg Glob Open. 2019; 7: e2361
        • Bouazzi D.
        • Chafranska L.
        • Saunte D.M.L.
        • Jemec G.B.E
        Systematic review of complications and recurrences after surgical interventions in hidradenitis suppurativa.
        Dermatol Surg. 2020; 46: 914-921
        • Burney R.E.
        35-year experience with surgical treatment of hidradenitis suppurativa.
        World J Surg. 2017; 41: 2723-2730
        • Jemec G.B.
        • Guérin A.
        • Kaminsky M.
        • Okun M.
        • Sundaram M
        What happens after a single surgical intervention for hidradenitis suppurativa? A retrospective claims-based analysis.
        J Med Econ. 2016; 19: 710-717